Story · Medicine & Biotech

Karine Tawagi: Phase II Proposal Explores Capivasertib Strategies in PTEN-Deficient Prostate Cancer

1 outlet · first reported by OncoDaily on

Karine Tawagi, assistant Professor of Clinical Medicine and Hematology/Oncology Fellowship Program Director at the University of Illinois Chicago, shared on X: “Phase II proposal for PTEN-deficient mAMPS. Patients with greater than (OncoDaily)

Coverage, in order

  1. OncoDaily obscure study randomized trial
    Karine Tawagi: Phase II Proposal Explores Capivasertib Strategies in PTEN-Deficient Prostate Cancer

    Karine Tawagi, assistant Professor of Clinical Medicine and Hematology/Oncology Fellowship Program Director at the University of Illinois Chicago, shared on X: “Phase II proposal for PTEN-deficient mAMPS. Patients with greater than

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.